The Mini-BESTest presented an excellent inter-rater reliability (ICC 2,1= 0.95, 95% CI = 0.91–0.97, SEM = 0.61) and an excellent intra-rater reliability (ICC 3,1 = 0.93, 95% CI = 0.87–0.96, SEM = 0.66), with confirmation by a good agreement presented by the Bland–Altman plots. Inter-rater (two physiotherapists) and Intra-rater (7–10 days) reliability of the Mini-BESTest were explored with intraclass correlation coefficients (ICC 2,1) and (ICC 3,1). Diabetic peripheral neuropathy was diagnosed by physical assessment using the Michigan Neuropathy Screening Instrument (MNSI). Therefore, a cross-sectional study design was conducted including 44 type 2 diabetic patients (4 males and 40 females aged 56.61 ± 7.7 years old). The current study aimed to examine the reliability and discriminant validity by comparing the Mini-BESTest scores between type 2 diabetic patients with peripheral neuropathy, divided into two 2 groups based on reporting scores of <4 and ≥4 in the MNSI questionnaire, respectively. No prior studies have yet been conducted to assess the usefulness of Mini-BESTest in the diagnosis of type 2 diabetic peripheral neuropathy. The Mini-BESTest, a shortened version of BESTest, was evolved to identify balance disorders within a short duration. Type 2 diabetic peripheral neuropathy is known to cause balance limitations in static, dynamic, and functional activity.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |